Use of a plasma test for verifying epidermal growth factor receptor gene (EGFR) mutations in fluid samples from non-small cell lung cancer patients

Use of a plasma test for verifying epidermal growth factor receptor gene (EGFR) mutations in fluid samples from non-small cell lung cancer patients

Because epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) are effective in the treatment of non-small cell lung cancer (NSCLC) patients with EGFR mutations, it is critical to obtain accurate EGFR mutation test results. For NSCLC patients, EGFR mutation testing is performed usin...

Full description

Bibliographic Details
Main Authors: Wataru Ogura, Kouki Ohtsuka, Masachika Fujiwara, Ryota Tanaka, Kumiko Sekiguchi, Hiroaki Ohnishi, Takashi Watanabe
Format: Article
Language:English
Published: Elsevier 2020-01-01
Series:Respiratory Medicine Case Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2213007119302692

Internet

http://www.sciencedirect.com/science/article/pii/S2213007119302692

Similar Items